Page last updated: 2024-08-24

valsartan and Syndrome

valsartan has been researched along with Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Li, D; Liu, Q; Xie, Y; Yan, J1
Rickenbacher, P1
Hasenfuss, G1
Millar, AB; Thickett, DR1

Reviews

1 review(s) available for valsartan and Syndrome

ArticleYear
[Heart failure with "mid-range" ejection fraction: a new clinical entity?]
    Therapeutische Umschau. Revue therapeutique, 2018, Volume: 75, Issue:3

    Topics: Aged; Aminobutyrates; Benzimidazoles; Biomarkers; Biphenyl Compounds; Comorbidity; Coronary Disease; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Natriuretic Peptides; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Spironolactone; Stroke Volume; Survival Rate; Syndrome; Tetrazoles; Valsartan

2018

Trials

1 trial(s) available for valsartan and Syndrome

ArticleYear
[AT(1) blocker for post-infarct therapy. VALIANT Study].
    Der Internist, 2004, Volume: 45, Issue:8

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Survival Analysis; Syndrome; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left

2004

Other Studies

2 other study(ies) available for valsartan and Syndrome

ArticleYear
Effect of Yiqi Huayu Pinggan Zishen Formula Combined with Valsartan in the Treatment of Hypertension and Its Effect on MMP-9, Ang II, and MCP-1.
    Computational and mathematical methods in medicine, 2022, Volume: 2022

    Topics: Angiotensin II; Antihypertensive Agents; Chemokine CCL2; Drugs, Chinese Herbal; Humans; Hypertension; Matrix Metalloproteinase 9; Syndrome; Valsartan

2022
Drug-induced antisynthetase syndrome.
    Postgraduate medical journal, 1997, Volume: 73, Issue:857

    Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents; Arthritis; Autoantibodies; Autoimmune Diseases; Cytoskeleton; Humans; Male; Prednisolone; Pulmonary Fibrosis; Raynaud Disease; Skin Diseases; Syndrome; Tetrazoles; Valine; Valsartan

1997